Archived Insight | April 19, 2022

The National Public Health Emergency Extended into July

Effective April 12, 2022, the federal government extended the COVID-19 public health emergency for at least an additional 90 days, until mid-July.

This is the ninth extension of the emergency, which the secretary of the Department of Health and Human Services (HHS) declared on January 31, 2020 (retroactive to January 27, 2020). The HHS secretary could terminate the public health emergency earlier than mid-July or extend it again.

The National Public Health Emergency Extended into July

Before the public health emergency expires, HHS has indicated it will give at least a 60-day notice.

Why this matters

This public emergency declaration is important to health plan sponsors because it determines the period during which group health plans and insurers must pay for COVID-19 tests and related services without charging cost sharing. In addition, non-grandfathered plans must cover vaccines in network as a preventive benefit, but during the public emergency must also cover them on an out-of-network basis. To learn more, see our December 15, 2020 insight, “Most Plans Must Cover COVID-19 Vaccine Without Cost Sharing.”

Plan sponsors should ensure plans are administered consistently with the requirements for the public health emergency.

Earlier this year, the National Emergency was extended into 2023

Other plan requirements, most notably the requirement to extend certain deadlines related to COBRA, special enrollment, and claims and appeals, are pegged to a different COVID-19 emergency declaration — the national emergency. President Trump made that declaration on March 13, 2020, retroactive to March 1, 2020. That emergency declaration does not expire automatically. On February 18, 2022, President Biden extended the national emergency until March 1, 2023.

Have questions about how the emergency declarations affect your health plan?

We have answers.

Get in Touch

See more insights

Doctor With Psoriasis Patient

Q3 2025 Trends Focus: Specialty Dermatological Drugs

Learn about the rising cost of these drugs, emerging therapies for psoriasis, the biosimilar market and four cost-management strategies.
Doctor Explaining The Diagnosis To A Girl And Her Father In The Consultation Room

Budget Act Provisions that Affect Employee Benefits

Plan sponsors: Review several parts of the bill, particularly those related to Health Savings Accounts (HSAs) and certain other fringe benefits.
Female Doctor Pushing Senior Woman On Wheelcair

ACA Dollar Amounts and Percentages

We updated the charts to include the Department of Health and Human Services’ revised maximum annual limits on cost-sharing for 2026, which increased.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.